Haemonetics Corporation

NYSE: HAE · Real-Time Price · USD
53.11
0.78 (1.49%)
At close: Aug 15, 2025, 10:00 AM

Haemonetics Balance Sheet Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 29, 2025 Mar 30, 2024 Apr 1, 2023 Apr 2, 2022 Apr 3, 2021
Cash & Equivalents
306.76M 178.8M 284.47M 259.5M 192.31M
Short-Term Investments
n/a n/a 1.11M n/a n/a
Long-Term Investments
n/a n/a n/a n/a -6.01M
Other Long-Term Assets
164.11M 81.12M 106.97M 63.2M 76.89M
Receivables
202.66M 206.56M 179.14M 159.38M 127.56M
Inventory
365.14M 317.2M 259.38M 293.03M 322.61M
Other Current Assets
60.41M 66.34M 46.73M 44.13M 51.07M
Total Current Assets
934.98M 768.9M 769.72M 756.03M 693.55M
Property-Plant & Equipment
284.05M 366.63M 310.88M 258.48M 217.56M
Goodwill & Intangibles
1.06B 971.2M 742M 777.55M 831.93M
Total Long-Term Assets
1.52B 1.43B 1.17B 1.1B 1.13B
Total Assets
2.45B 2.2B 1.93B 1.86B 1.82B
Account Payables
67M 73.36M 63.93M 58.37M 50.29M
Deferred Revenue
43.35M 31.24M 30.21M 31.83M 26.27M
Short-Term Debt
303.56M 10.23M 11.78M 214.15M 17.02M
Other Current Liabilities
104.78M 104.85M 81.42M 82.19M 85.38M
Total Current Liabilities
578.11M 300.38M 251.82M 442.27M 253.5M
Long-Term Debt
921.23M 797.56M 754.1M 559.44M 690.59M
Other Long-Term Liabilities
68.19M 75.04M 74.72M 79.88M 37.38M
Total Long-Term Liabilities
1.05B 935.25M 865.01M 668.04M 834.76M
Total Liabilities
1.63B 1.24B 1.12B 1.11B 1.09B
Total Debt
1.22B 807.79M 765.89M 773.59M 707.61M
Common Stock
482K 508K 504K 511K 509K
Retained Earnings
352.17M 360.46M 253.17M 202.39M 157.98M
Comprehensive Income
-55.08M -35.63M -30.38M -25.95M -29.55M
Shareholders Equity
820.84M 959.96M 818M 749.42M 731.67M
Total Investments
n/a -7.74M 1.11M n/a -6.01M